Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human GDF9 Protein, N-His

Catalog #:   YHA89801 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: O60383
Protein length: Gly320-Arg454
Overview

Catalog No.

YHA89801

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Gly320-Arg454

Predicted molecular weight

17.80 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

O60383

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Growth/differentiation factor 9, GDF-9, GDF9

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human GDF9 protein
References

Roles of GDF9 and BMP15 in equine follicular development: in vivo content and in vitro effects of IGF1 and cortisol on granulosa cells., PMID:40289073

Regulating human oocyte maturation in vitro: a hypothesis based on oocytes retrieved from small antral follicles during ovarian tissue cryopreservation., PMID:40261459

Impact of female age on concentrations of reproductive hormones and oocyte-specific growth factors in follicular fluid from human small antral follicles., PMID:39922201

Pro-cumulin addition in a biphasic in vitro oocyte maturation system modulates human oocyte and cumulus cell transcriptomes., PMID:39862403

Combination of FSH and testosterone could enhance activation of primordial follicles and growth of activated follicles in 1-day-old mice ovaries in vitro cultured for 12 days., PMID:39710995

Oocyte-derived growth differentiation factor 9 suppresses the expression of CYP17A1 and androgen production in human theca cells., PMID:39382269

Novel Insight into the mechanism of di (2-ethylhexyl) phthalate (DEHP) impairing early follicle development., PMID:39293100

Revisiting GDF9 variants in primary ovarian insufficiency: A shift from dominant to recessive pathogenicity?, PMID:38942181

Prenatal acetaminophen exposure and the developing ovary: Time, dose, and course consequences for fetal mice., PMID:38657942

GDF9His209GlnfsTer6/S428T and GDF9Q321X/S428T bi-allelic variants caused female subfertility with defective follicle enlargement., PMID:38643161

In-vitro generation of follicle-like structures from human germ cell-like cells derived from theca stem cell combined with ovarian somatic cells., PMID:38167472

Interleukin 17 and Growth Differentiation Factor 9 Influence in a Sample of Iraqi Infertile Males., PMID:38028840

Implication of Novel BMP15 and GDF9 Variants in Unexpected Poor Ovarian Response., PMID:37848645

Decreased growth differentiation factor 9, bone morphogenetic protein 15, and forkhead box O3a expressions in the ovary via ulipristal acetate., PMID:37585996

Decreased GDF9 and BMP15 in follicle fluid and granulosa cells and outcomes of IVF-ET among young patients with low prognosis., PMID:36689045

Resolving the challenge of insoluble production of mature human growth differentiation factor 9 protein (GDF9) in E. coli using bicistronic expression with thioredoxin., PMID:36649874

Oocyte-Secreted Serum Biomarkers GDF9 and BMP15 in Women with Endometriosis., PMID:36380138

Serum GDF9 and BMP15 as potential markers of ovarian function in women with and without polycystic ovary syndrome., PMID:36372988

Concentrations of oocyte secreted GDF9 and BMP15 decrease with MII transition during human IVM., PMID:35986324

Intrafollicular Concentrations of the Oocyte-secreted Factors GDF9 and BMP15 Vary Inversely in Polycystic Ovaries., PMID:35511085

Sitagliptin/metformin improves the fertilization rate and embryo quality in polycystic ovary syndrome patients through increasing the expression of GDF9 and BMP15: A new alternative to metformin (a randomized trial)., PMID:35217236

The boosting effects of melatonin on the expression of related genes to oocyte maturation and antioxidant pathways: a polycystic ovary syndrome- mouse model., PMID:35057828

Ovarian insufficiency and secondary amenorrhea in a patient with a novel variant within GDF9 gene., PMID:35013061

Effect of cumulin and super-GDF9 in standard and biphasic mouse IVM., PMID:34984599

A frameshift deletion in the GDF9 gene in Icelandic Loa prolific sheep., PMID:34967038

CPEB3 deficiency in mice affect ovarian follicle development and causes premature ovarian insufficiency., PMID:34930897

GDF9 concentration in embryo culture medium is linked to human embryo quality and viability., PMID:34845575

Regulation of GDF9 and CDKN1B expression in Tibetan sheep testes during different stages of maturity., PMID:34826605

Taurine improves follicular survival and function of mice ovarian grafts through increasing CD31 and GDF9 expression and reducing oxidative stress and apoptosis., PMID:33940031

Abnormal early folliculogenesis due to impeded pyruvate metabolism in mouse oocytes†., PMID:33824958

A homozygous truncating variant in GDF9 in siblings with primary ovarian insufficiency., PMID:33797006

Exploratory analysis of serum concentrations of oocyte biomarkers growth differentiation factor 9 and bone morphogenetic protein 15 in ovulatory women across the menstrual cycle., PMID:33775397

New insights into the GDF9-Hedgehog-GLI signaling pathway in human ovaries: from fetus to postmenopause., PMID:33772413

Single-cell transcriptome dissection of the toxic impact of Di (2-ethylhexyl) phthalate on primordial follicle assembly., PMID:33754040

Association of FSHR, LH, LHR, BMP15, GDF9, AMH, and AMHR polymorphisms with poor ovarian response in patients undergoing in vitro fertilization., PMID:33739800

Polymorphism Detection of GDF9 Gene and Its Association with Litter Size in Luzhong Mutton Sheep (Ovis aries)., PMID:33671790

Activation-induced cytidine deaminase is a possible regulator of cross-talk between oocytes and granulosa cells through GDF-9 and SCF feedback system., PMID:33589683

Genetic etiologic analysis in 74 Chinese Han women with idiopathic premature ovarian insufficiency by combined molecular genetic testing., PMID:33538981

Age-related decline in the expression of GDF9 and BMP15 genes in follicle fluid and granulosa cells derived from poor ovarian responders., PMID:33397408

New insights into the genetic basis of premature ovarian insufficiency: Novel causative variants and candidate genes revealed by genomic sequencing., PMID:33036707

The Effect of Isotretinoin on Oocyte Maturation in Adolescent Female Rats., PMID:32894850

GDF9 polymorphisms: influence on ovarian response in women undergoing controlled ovarian hyperstimulation., PMID:32510893

A variant of human growth differentiation factor-9 that improves oocyte developmental competence., PMID:32350111

Prediction of ovarian aging using ovarian expression of BMP15, GDF9, and C-KIT., PMID:32223330

Rapamycin preserves the primordial follicle pool during cisplatin treatment in vitro and in vivo., PMID:32112509

Growth differentiation factor 9 inhibits vascular endothelial growth factor expression in human granulosa cells., PMID:31996061

The antioxidant curcumin postpones ovarian aging in young and middle-aged mice., PMID:31656219

The role of BMP15 and GDF9 in the pathogenesis of primary ovarian insufficiency., PMID:31607184

Regulation of Insulin-Like Growth Factor 2 by Oocyte-Secreted Factors in Primary Human Granulosa Cells., PMID:31588501

Association of BMP15 and GDF9 variants to premature ovarian insufficiency., PMID:31392662

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human GDF9 Protein, N-His [YHA89801]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only